Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
GBX
|
Brian J Comstock
EVP & President, The Americas |
SELL
Payment of exercise price or tax liability
|
Direct | 1,666 Reduced 4.62% |
$75,753
$45.47 p/Share
|
Oct 17
2025 |
|
PRTS
|
Ryan Lockwood
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,709 Reduced 3.12% |
$4,427
$0.66 p/Share
|
Oct 17
2025 |
|
JNJ
|
John C Reed
EVP, Innovative Medicine, R&D |
SELL
Open market or private sale
|
Direct | 21,721 Reduced 67.08% |
$4,185,853
$192.71 p/Share
|
Oct 17
2025 |
|
JNJ
|
John C Reed
EVP, Innovative Medicine, R&D |
BUY
Exercise of conversion of derivative security
|
Direct | 21,721 Added 40.15% |
$3,430,180
$157.92 p/Share
|
Oct 17
2025 |
|
PRTS
|
David Meniane
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 22,217 Reduced 1.19% |
$14,663
$0.66 p/Share
|
Oct 17
2025 |
|
LVTX
|
Gilde Healthcare Iv U.A. Cooperatieve |
SELL
Open market or private sale
|
Direct | 1,181,131 Reduced 28.61% |
$1,736,262
$1.47 p/Share
|
Oct 17
2025 |
|
RMI
|
River North Financial Holdings, LLC |
BUY
Open market or private purchase
|
Direct | 4,138 Added 23.51% |
$60,497
$14.62 p/Share
|
Oct 17
2025 |
|
UWMC
|
Ishbia Mat
President and CEO |
SELL
Open market or private sale
|
Indirect | 596,356 Reduced 0.0% |
$3,202,431
$5.37 p/Share
|
Oct 17
2025 |
|
DC
|
Stephen T. O'Rourke
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 4.91% |
$238,499
$4.77 p/Share
|
Oct 17
2025 |
|
SHLS
|
Dominic Bardos
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,758 Reduced 0.42% |
$17,492
$9.95 p/Share
|
Oct 17
2025 |
|
CRSP
|
Samarth Kulkarni
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 50,895 Reduced 16.68% |
$3,456,279
$67.91 p/Share
|
Oct 17
2025 |
|
OPP
|
Stephen Andrew O'Neill |
BUY
Open market or private purchase
|
Direct | 30 Added 0.48% |
$247
$8.26 p/Share
|
Oct 17
2025 |
|
ASA
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 81,855 Added 0.0% |
$4,039,544
$49.35 p/Share
|
Oct 17
2025 |
|
OMEX
|
Mark Gordon
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 5.53% |
$105,000
$3.5 p/Share
|
Oct 17
2025 |
|
OUST
|
Megan Chung
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 5,836 Reduced 2.87% |
$181,032
$31.02 p/Share
|
Oct 17
2025 |
|
GRX
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,816 Added 0.0% |
$53,507
$9.2 p/Share
|
Oct 17
2025 |
|
ESPR
|
Benjamin Looker
General Counsel |
SELL
Open market or private sale
|
Direct | 1,248 Reduced 0.32% |
$3,269
$2.62 p/Share
|
Oct 17
2025 |
|
RVMD
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 2.12% |
$11,200
$1.12 p/Share
|
Oct 17
2025 |
|
RVMD
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 2.16% |
$550,000
$55.0 p/Share
|
Oct 17
2025 |
|
RVMD
|
Jeff Cislini
General Counsel |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 19.22% |
$660,000
$55.0 p/Share
|
Oct 17
2025 |
|
RVMD
|
Jeff Cislini
General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 12,000 Added 16.12% |
$438,840
$36.57 p/Share
|
Oct 17
2025 |
|
JAMF
|
John Strosahl
CEO |
SELL
Open market or private sale
|
Direct | 43,650 Reduced 2.86% |
$431,262
$9.88 p/Share
|
Oct 17
2025 |
|
SMRT
|
Daryl Stemm
CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 350 Reduced 0.42% |
$511
$1.46 p/Share
|
Oct 17
2025 |
|
SMRT
|
Daryl Stemm
CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 834 Added 0.99% |
-
|
Oct 17
2025 |
|
SMRT
|
Isaiah De Rose Wilson
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 465 Reduced 0.41% |
$678
$1.46 p/Share
|
Oct 17
2025 |
|
SMRT
|
Isaiah De Rose Wilson
Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,111 Added 0.97% |
-
|
Oct 17
2025 |
|
BRT
|
Investors L P Gould |
BUY
Open market or private purchase
|
Direct | 3,953 Added 0.1% |
$59,176
$14.97 p/Share
|
Oct 17
2025 |
|
BRT
|
Matthew J Gould
SENIOR VICE PRESIDENT |
BUY
Open market or private purchase
|
Indirect | 3,953 Added 0.0% |
$59,176
$14.97 p/Share
|
Oct 17
2025 |
|
BRT
|
Jeffrey Gould
PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Indirect | 3,953 Added 0.0% |
$59,176
$14.97 p/Share
|
Oct 17
2025 |
|
MSTR
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct | 12,000 Added 29.03% |
$1,162,560
$96.88 p/Share
|
Oct 17
2025 |
|
LECO
|
Gabriel Bruno
EVP, CFO & TREASURER |
SELL
Payment of exercise price or tax liability
|
Direct | 261 Reduced 0.88% |
$61,340
$235.02 p/Share
|
Oct 17
2025 |
|
UTHR
|
Martine A Rothblatt
Chairperson & CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 96.85% |
$1,724,720
$431.18 p/Share
|
Oct 17
2025 |
|
UTHR
|
Martine A Rothblatt
Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 4,000 Added 49.2% |
$481,040
$120.26 p/Share
|
Oct 17
2025 |
|
MBX
|
Steven L. Hoerter |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 0.0% |
$265,000
$13.25 p/Share
|
Oct 17
2025 |
|
PAYO
|
Beatrice Ordonez
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 60,485 Reduced 2.52% |
$345,974
$5.72 p/Share
|
Oct 17
2025 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,250 Reduced 0.02% |
$554,692
$246.53 p/Share
|
Oct 17
2025 |
|
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,250 Added 0.02% |
$363,375
$161.5 p/Share
|
Oct 17
2025 |
|
APDN
|
Clay Shorrock
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 18,691 Added 49.99% |
-
|
Oct 17
2025 |
|
APDN
|
Judith Murrah
Director |
BUY
Grant, award, or other acquisition
|
Direct | 18,691 Added 50.0% |
-
|
Oct 17
2025 |
|
AREC
|
Golden Properties Ltd. |
SELL
Open market or private sale
|
Direct | 980,000 Reduced 7.91% |
$3,978,799
$4.06 p/Share
|
Oct 17
2025 |
|
TENB
|
Barron Anschutz |
SELL
Open market or private sale
|
Direct | 976 Reduced 1.56% |
$28,401
$29.1 p/Share
|
Oct 17
2025 |
|
APDN
|
Yacov A Shamash
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
CNS
|
Michael T. Donohue
Interim CFO, SVP |
BUY
Grant, award, or other acquisition
|
Direct | 2,154 Added 7.65% |
-
|
Oct 17
2025 |
|
APDN
|
Elizabeth M. Ferguson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
APDN
|
Beth Jantzen
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 18,691 Added 50.0% |
-
|
Oct 17
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,156,801
$150.92 p/Share
|
Oct 17
2025 |
|
APDN
|
Robert B Catell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,156,801
$150.92 p/Share
|
Oct 17
2025 |
|
APDN
|
Joseph D. Ceccoli
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
AZO
|
Philip B. Daniele
President & CEO |
SELL
Open market or private sale
|
Direct | 2,533 Reduced 97.91% |
$10,187,295
$4021.83 p/Share
|
Oct 17
2025 |